InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Lenk Robert P, Director. Director active across 1 companies, notably Plus Therapeutics, INC.. In total, 2 filings have been published. Total volume traded: €22k. The latest transaction was disclosed on 13 September 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
€11,0157,000 shares@ €1.5736100.0% of flow
Common Stock
SEC:0001209191-21-056096·
Ideal exit: 10 Jun 2022 (T+270)
€11,0157,000 shares@ €1.57360.031% mcap50.0% of flow
Common Stock
SEC:0001209191-21-056096:0·
Ideal exit: 10 Jun 2022 (T+270)
2 of 2 declarations
About Lenk Robert P
Robert P. Lenk serves as a Board Member at PLUS Therapeutics, Inc. In this role, he participates in the governance of the company, providing his expertise to assist in strategic decision-making. His experience in the biopharmaceutical sector allows him to contribute to the company's direction and performance improvement.
